Related references
Note: Only part of the references are listed.Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML
C. D. DiNardo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers
Janeta Popovici-Muller et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
MS-based lipidomics of human blood plasma: a community-initiated position paper to develop accepted guidelines
Bo Burla et al.
JOURNAL OF LIPID RESEARCH (2018)
Lipid metabolism reprogramming and its potential targets in cancer
Chunming Cheng et al.
CANCER COMMUNICATIONS (2018)
Mutant IDH1 gliomas downregulate phosphocholine and phosphoethanolamine synthesis in a 2-hydroxyglutarate-dependent manner
Pavithra Viswanath et al.
CANCER & METABOLISM (2018)
An optimized method for measuring fatty acids and cholesterol in stable isotope-labeled cells
Joseph P. Argus et al.
JOURNAL OF LIPID RESEARCH (2017)
Urinary lysophopholipids are increased in diabetic patients with nephropathy
Jean-Sebastien Saulnier-Blache et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2017)
Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI
Shanshan Jiang et al.
MAGNETIC RESONANCE IN MEDICINE (2017)
Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism
Thomas Farge et al.
CANCER DISCOVERY (2017)
Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients
Franck Chiappini et al.
SCIENTIFIC REPORTS (2017)
IDH Mutation, Competitive Inhibition of FTO, and RNA Methylation
Sara M. Elkashef et al.
CANCER CELL (2017)
Acid Ceramidase Deficiency in Mice Results in a Broad Range of Central Nervous System Abnormalities
Jakub Sikora et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Understanding the Intersections between Metabolism and Cancer Biology
Matthew G. Vander Heiden et al.
CELL (2017)
Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia
Helena Boutzen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Sterol Regulatory Element Binding Protein Regulates the Expression and Metabolic Functions of Wild-Type and Oncogenic IDH1
Stephane J. H. Ricoult et al.
MOLECULAR AND CELLULAR BIOLOGY (2016)
PHD3 Loss in Cancer Enables Metabolic Reliance on Fatty Acid Oxidation via Deactivation of ACC2
Natalie J. German et al.
MOLECULAR CELL (2016)
The Warburg Effect: How Does it Benefit Cancer Cells?
Maria V. Liberti et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
Lipid metabolic reprogramming in cancer cells
S. Beloribi-Djefaflia et al.
ONCOGENESIS (2016)
The multifaceted roles of fatty acid synthesis in cancer
Florian Roehrig et al.
NATURE REVIEWS CANCER (2016)
A roadmap for interpreting 13C metabolite labeling patterns from cells
Joerg M. Buescher et al.
CURRENT OPINION IN BIOTECHNOLOGY (2015)
Nutrient-sensing mechanisms and pathways
Alejo Efeyan et al.
NATURE (2015)
Metabolic pathways promoting cancer cell survival and growth
Lindsey K. Boroughs et al.
NATURE CELL BIOLOGY (2015)
Metabolic Reprogramming in Mutant IDH1 Glioma Cells
Jose L. Izquierdo-Garcia et al.
PLOS ONE (2015)
Lipid landscapes and pipelines in membrane homeostasis
Joost C. M. Holthuis et al.
NATURE (2014)
Cancer Cells Differentially Activate and Thrive on De Novo Lipid Synthesis Pathways in a Low-Lipid Environment
Veerle W. Daniels et al.
PLOS ONE (2014)
Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment
Daniel Ackerman et al.
TRENDS IN CELL BIOLOGY (2014)
Re-Configuration of Sphingolipid Metabolism by Oncogenic Transformation
Anthony S. Don et al.
BIOMOLECULES (2014)
Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development
Franziska Baenke et al.
DISEASE MODELS & MECHANISMS (2013)
Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids
Jurre J. Kamphorst et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells
Dan Rohle et al.
SCIENCE (2013)
IsoCor: correcting MS data in isotope labeling experiments
Pierre Millard et al.
BIOINFORMATICS (2012)
Expanding the Reach of Cancer Metabolomics
Christian M. Metallo
CANCER PREVENTION RESEARCH (2012)
Genetically-defined metabolic reprogramming in cancer
Andrew R. Mullen et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics
Wen-Chien Chou et al.
BLOOD (2011)
Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases
Wei Xu et al.
CANCER CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
Rasheduzzaman Chowdhury et al.
EMBO REPORTS (2011)
Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome
Zachary J. Reitman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability
David R. Wise et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Tracing the fate of dietary fatty acids: metabolic studies of postprandial lipaemia in human subjects
Barbara Fielding
PROCEEDINGS OF THE NUTRITION SOCIETY (2011)
The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
Patrick S. Ward et al.
CANCER CELL (2010)
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
Maria E. Figueroa et al.
CANCER CELL (2010)
Prognostic Impact of Isocitrate Dehydrogenase Enzyme Isoforms 1 and 2 Mutations in Acute Myeloid Leukemia: A Study by the Acute Leukemia French Association Group
Nicolas Boissel et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
Guido Marcucci et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
IDH1 and IDH2 Mutations Are Frequent Genetic Alterations in Acute Myeloid Leukemia and Confer Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia With NPM1 Mutation Without FLT3 Internal Tandem Duplication
Peter Paschka et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations
Stefan Gross et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Rapid measurement of plasma free fatty acid concentration and isotopic enrichment using LC/MS
Xuan-Mai T. Persson et al.
JOURNAL OF LIPID RESEARCH (2010)
Activation of p53 signaling by MI-63 induces apoptosis in acute myeloid leukemia cells
Ismael J. Samudio et al.
LEUKEMIA & LYMPHOMA (2010)
Lipid Rafts As a Membrane-Organizing Principle
Daniel Lingwood et al.
SCIENCE (2010)
Cancer genome sequencing: a review
Elaine R. Mardis et al.
HUMAN MOLECULAR GENETICS (2009)
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Lenny Dang et al.
NATURE (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
High Fat Feeding Induces Hepatic Fatty Acid Elongation in Mice
Maaike H. Oosterveer et al.
PLOS ONE (2009)
Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α
Shimin Zhao et al.
SCIENCE (2009)
Cancer cell metabolism: Warburg and beyond
Peggy P. Hsu et al.
CELL (2008)
Membrane lipids: where they are and how they behave
Gerrit van Meer et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis
Ralph J. DeBerardinis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Javier A. Menendez et al.
NATURE REVIEWS CANCER (2007)
Up-regulation of Acetyl-CoA carboxylase α and fatty acid synthase by human epidermal growth factor receptor 2 at the translational level in breast cancer cells
Sarah Yoon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Share Paper
